US Patent Issued to Merck Sharp & Dohme on July 1 for "2-amino-n-phenyl-nicotinamides as NAV1.8 inhibitors" (Pennsylvania, New Jersey Inventors)

ALEXANDRIA, Va., July 3 -- United States Patent no. 12,344,595, issued on July 1, was assigned to Merck Sharp & Dohme LLC (Rahway, N.J.).

"2-amino-n-phenyl-nicotinamides as NAV1.8 inhibitors" was invented by Michael J. Breslin (Drexel Hill, Pa.), Christopher James Bungard (Lansdale, Pa.), Harry R. Chobanian (Westfield, N.J.), Kristen L. G. Jones (Oreland, Pa.), Mark E. Layton (Harleysville, Pa.), Jian Liu (Edison, N.J.), James J. Perkins (Churchville, Pa.), Jeffrey William Schubert (North Wales, Pa.), Shawn J. Stachel (Perkasie, Pa.), Linda M. Suen-Lai (Philadelphia) and Zhe Wu (Blue Bell, Pa.).

According to the abstract* released by the U.S. Patent & Trademark Office: "Novel compounds of the structural formula (I), and the pharmaceutical...